<DOC>
	<DOCNO>NCT01052259</DOCNO>
	<brief_summary>The purpose study examine efficacy safety cycle treatment deoxyspergualin renal transplant patient biopsy-proven chronic rejection .</brief_summary>
	<brief_title>Efficacy Safety Deoxyspergualin Renal Transplant Patient With Chronic Rejection</brief_title>
	<detailed_description>The primary aim study investigate efficacy deoxyspergualin completion 6 cycle treatment . The efficacy valuables histological finding renal graft , renal function , proteinuria , graft survival , anti-HLA antibody . The safety data also evaluate study .</detailed_description>
	<mesh_term>Gusperimus</mesh_term>
	<criteria>Chronic rejection define Banff 2007 criterion Patients recurrent renal disease virusassociated renal disease Patients initial WBC &lt; 4,000 , neutrophil &lt; 1,000 , platelet &lt; 50,000 Hb &lt; 8g Patients acute chronic infection</criteria>
	<gender>All</gender>
	<minimum_age>11 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>Chronic rejection</keyword>
	<keyword>Kidney</keyword>
	<keyword>Transplantation</keyword>
	<keyword>Immunosuppressive</keyword>
</DOC>